These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29027217)

  • 1. Danger signals: Chemotherapy enhancers?
    Rivera Vargas T; Apetoh L
    Immunol Rev; 2017 Nov; 280(1):175-193. PubMed ID: 29027217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
    Iurescia S; Fioretti D; Rinaldi M
    Front Immunol; 2018; 9():711. PubMed ID: 29686682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for stimulator of interferon genes-targeted cancer immunotherapy.
    Rivera Vargas T; Benoit-Lizon I; Apetoh L
    Eur J Cancer; 2017 Apr; 75():86-97. PubMed ID: 28219022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
    Iurescia S; Fioretti D; Rinaldi M
    Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and radiotherapy: cryptic anticancer vaccines.
    Ma Y; Kepp O; Ghiringhelli F; Apetoh L; Aymeric L; Locher C; Tesniere A; Martins I; Ly A; Haynes NM; Smyth MJ; Kroemer G; Zitvogel L
    Semin Immunol; 2010 Jun; 22(3):113-24. PubMed ID: 20403709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Cancer Immunotherapy Via Activation of Innate Immunity.
    Goldberg JL; Sondel PM
    Semin Oncol; 2015 Aug; 42(4):562-72. PubMed ID: 26320061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
    Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
    Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines to treat cancer--an old approach whose time has arrived.
    Hellstrom KE; Hellstrom I
    J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nuclear macromolecules in innate immunity.
    Pisetsky DS
    Proc Am Thorac Soc; 2007 Jul; 4(3):258-62. PubMed ID: 17607009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensing necrotic cells.
    Miyake Y; Yamasaki S
    Adv Exp Med Biol; 2012; 738():144-52. PubMed ID: 22399378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-death-associated molecular patterns as determinants of cancer immunogenicity.
    Ladoire S; Hannani D; Vetizou M; Locher C; Aymeric L; Apetoh L; Kepp O; Kroemer G; Ghiringhelli F; Zitvogel L
    Antioxid Redox Signal; 2014 Mar; 20(7):1098-116. PubMed ID: 23394620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.
    Michelle Xu M; Pu Y; Weichselbaum RR; Fu YX
    Oncogene; 2017 Feb; 36(5):585-592. PubMed ID: 27425593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
    Nelson MH; Diven MA; Huff LW; Paulos CM
    J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
    Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
    Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Local Radiation Therapy in Cancer Immunotherapy.
    Demaria S; Golden EB; Formenti SC
    JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.